Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1060
-
Total 13F shares, excl. options
-
92.7M
-
Shares change
-
-345K
-
Total reported value, excl. options
-
$63.9B
-
Value change
-
-$196M
-
Put/Call ratio
-
1.3
-
Number of buys
-
460
-
Number of sells
-
-495
-
Price
-
$688.87
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2022
1,206 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2022.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,060 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.7M shares
of 105M outstanding shares and own 88.32% of the company stock.
Largest 10 shareholders include FMR LLC (10.8M shares), BlackRock Inc. (9.49M shares), VANGUARD GROUP INC (8.65M shares), Capital World Investors (6.23M shares), JPMORGAN CHASE & CO (5.71M shares), STATE STREET CORP (5.05M shares), WELLINGTON MANAGEMENT GROUP LLP (2.44M shares), Dodge & Cox (2.29M shares), GEODE CAPITAL MANAGEMENT, LLC (2.24M shares), and Capital International Investors (1.77M shares).
This table shows the top 1060 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.